These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8512758)

  • 1. The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine.
    Vree TB; Van Den Biggelaar-Martea M; Verwey-Van Wissen CP; Vree ML; Guelen PJ
    Br J Clin Pharmacol; 1993 May; 35(5):467-72. PubMed ID: 8512758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP; Vree JB; Guelen PJ
    Biopharm Drug Dispos; 1993 Aug; 14(6):491-502. PubMed ID: 8218967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of naproxen and its metabolite O-desmethylnaproxen with their acyl glucuronides in human plasma and urine by means of direct gradient high-performance liquid chromatography.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP
    J Chromatogr; 1992 Jul; 578(2):239-49. PubMed ID: 1400803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of cimetidine, ranitidine and famotidine on the single-dose pharmacokinetics of naproxen and its metabolites in humans.
    Vree TB; van den Biggelaar-Martea M; Verwey-van Wissen CP; Vree ML; Guelen PJ
    Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):597-601. PubMed ID: 8314361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous quantitative determination of naproxen, its metabolite 6-O-desmethylnaproxen and their five conjugates in plasma and urine samples by high-performance liquid chromatography on dynamically modified silica.
    Andersen JV; Hansen SH
    J Chromatogr; 1992 Jun; 577(2):325-33. PubMed ID: 1400763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjugation of desmethylnaproxen in the rat--a novel acyl glucuronide-sulfate diconjugate as a major biliary metabolite.
    Jaggi R; Addison RS; King AR; Suthers BD; Dickinson RG
    Drug Metab Dispos; 2002 Feb; 30(2):161-6. PubMed ID: 11792685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro regioselective stability of beta-1-O- and 2-O-acyl glucuronides of naproxen and their covalent binding to human serum albumin.
    Iwaki M; Ogiso T; Inagawa S; Kakehi K
    J Pharm Sci; 1999 Jan; 88(1):52-7. PubMed ID: 9874702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Naproxen and desmethylnaproxen glucuronidation by human liver microsomes and recombinant human UDP-glucuronosyltransferases (UGT): role of UGT2B7 in the elimination of naproxen.
    Bowalgaha K; Elliot DJ; Mackenzie PI; Knights KM; Swedmark S; Miners JO
    Br J Clin Pharmacol; 2005 Oct; 60(4):423-33. PubMed ID: 16187975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPLC/1H NMR spectroscopic studies of the reactive alpha-1-O-acyl isomer formed during acyl migration of S-naproxen beta-1-O-acyl glucuronide.
    Corcoran O; Mortensen RW; Hansen SH; Troke J; Nicholson JK
    Chem Res Toxicol; 2001 Oct; 14(10):1363-70. PubMed ID: 11599927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereospecific pH-dependent degradation kinetics of R- and S-naproxen-beta-l-O-acyl-glucuronide.
    Mortensen RW; Sidelmann UG; Tjørnelund J; Hansen SH
    Chirality; 2002 May; 14(4):305-12. PubMed ID: 11968070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-1H NMR used for determination of the elution order of S-naproxen glucuronide isomers in two isocratic reversed-phase LC-systems.
    Mortensen RW; Corcoran O; Cornett C; Sidelmann UG; Troke J; Lindon JC; Nicholson JK; Hansen SH
    J Pharm Biomed Anal; 2001 Jan; 24(3):477-85. PubMed ID: 11199227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling urinary metabolites of naproxen by liquid chromatography-electrospray mass spectrometry.
    Aresta A; Carbonara T; Palmisano F; Zambonin CG
    J Pharm Biomed Anal; 2006 Jun; 41(4):1312-6. PubMed ID: 16581219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S-naproxen-beta-1-O-acyl glucuronide degradation kinetic studies by stopped-flow high-performance liquid chromatography-1H NMR and high-performance liquid chromatography-UV.
    Mortensen RW; Corcoran O; Cornett C; Sidelmann UG; Lindon JC; Nicholson JK; Hansen SH
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):375-80. PubMed ID: 11259319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and identification of 6-desmethylnaproxen sulfate as a new metabolite of naproxen in human plasma.
    Kiang CH; Lee C; Kushinsky S
    Drug Metab Dispos; 1989; 17(1):43-8. PubMed ID: 2566468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interference by naproxen in the urinary 5-hydroxyindoleacetic acid assay is due to a metabolite, desmethylnaproxen.
    Walker PL; Pettit BR; Sandler M
    Ann Clin Biochem; 1987 Mar; 24 ( Pt 2)():177-81. PubMed ID: 2438972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of (R)- and (S)-naproxen and (R)- and (S)-6-O-desmethylnaproxen by high-performance liquid chromatography on a Chiral-AGP column.
    Andersen JV; Hansen SH
    J Chromatogr; 1992 Jun; 577(2):362-5. PubMed ID: 1400768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous separation of naproxen and 6-O-desmethylnaproxen metabolite in saliva samples by liquid chromatography-tandem mass spectrometry: Pharmacokinetic study of naproxen alone and associated with esomeprazole.
    Dionísio TJ; Oliveira GM; Morettin M; Faria FC; Santos CF; Calvo AM
    PLoS One; 2020; 15(8):e0236297. PubMed ID: 32780750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and synovial fluid kinetics, disposition, and urinary excretion of naproxen in horses.
    Soma LR; Uboh CE; Rudy JA; Perkowski SZ
    Am J Vet Res; 1995 Aug; 56(8):1075-80. PubMed ID: 8533980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct gradient reversed-phase HPLC analysis and preliminary pharmacokinetics of nalidixic acid, 7-hydroxymethylnalidixic acid, 7-carboxynalidixic acid, and their corresponding glucuronide conjugates in humans.
    Vree TB; van den Biggelaar-Martea M; van Ewijk-Beneken Kolmer EW; Hekster YA
    Pharm World Sci; 1993 Jun; 15(3):98-104. PubMed ID: 8348113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of the human kidney to the metabolic clearance of drugs.
    Vree TB; Hekster YA; Anderson PG
    Ann Pharmacother; 1992 Nov; 26(11):1421-8. PubMed ID: 1477449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.